REGULATION FOR DEVELOPMENT OF BIOSIMILAR : A REVIEW

Abstract

Present article signifies the exigency for regulation and regulatory bodies involved in development of biosimilars. The principle for development of biosimilars included opting adequate reference product, manufacturing process optimisation, quality control procedure, preclinical and clinical studies. India’s first guidelines were enforced in 2012, with amendments in 2016. Thus, we elaborated the amended guidelines for development of biosimilars. Keywords: Biosimilars; Manufacturing; Stability; Efficacy; India Guidelines.

Authors and Affiliations

Chauhan K Meenakshi| NDDS Research Lab, Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017, Gupta S K| Clinical Research Department, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017, Gupta Surbhi| Clinical Research Department, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017, Gulati Anshu| NDDS Research Lab, Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science and Research (DIPSAR), M. B. Road, Pushp Vihar, Sector - 3, New Delhi – 110017

Keywords

Related Articles

Formulation and evaluation pf Phospholipid complex of Green Tea Polyphenol

OBJECTIVE: Phospholipid complexes are formulated to improve absorption, bioavailability and stability of herbal product. There are many herbal extracts having excellent in-vitro activity but less in-vivo activity becau...

Design and evaluation of a Sustained Release Gastroretentive Dosage form of Captopril

Sustained drug delivery means not only prolonged duration of drug delivery but also implies predictability and reproducibility of drug release kinetics. In the present study gastroretentive dosage form (tablet) was sel...

Development and in-vitro evaluation of Furosemide Solid Dispersion using different Water Soluble Carriers

Objective: The objective of the present investigation was to improve solubility and dissolution characteristics of Furosemide, which might offer improved bioavailability. The bioavailability of the drug when taken oral...

Synthesis, characterization, antimicrobial and antitubercular activity of Some Pyrazoline derivatives from Chalcones bearing indane-1,3-dione as nucleus

A series of phenyl pyrazoline derivatives have been synthesized from chalcones of indane-1,3-dione. The substituted chalcones have already been synthesized and reported by us. The phenyl pyrazoline derivatives were syn...

Pharmacological aspects of Turbinaria

Seaweeds, are plant-like organisms that generally live attached to rock or other hard substrata in coastal areas. The brown color of these algae results from the dominance of the xanthophyll pigment fucoxanthin. Brown...

Download PDF file
  • EP ID EP15984
  • DOI -
  • Views 507
  • Downloads 144

How To Cite

Chauhan K Meenakshi, Gupta S K, Gupta Surbhi, Gulati Anshu (2016). REGULATION FOR DEVELOPMENT OF BIOSIMILAR : A REVIEW. International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL), 5(6), 2362-2368. https://europub.co.uk/articles/-A-15984